InvestorsHub Logo
Followers 61
Posts 11632
Boards Moderated 0
Alias Born 01/04/2015

Re: LearnToTrade post# 4617

Friday, 10/21/2016 8:34:25 AM

Friday, October 21, 2016 8:34:25 AM

Post# of 8449
They wouldn't need to run the company. If it's licensed, then I assume that the other pharma would be doing everything. Kitov, after all, is a one drug company with virtually no expenses other than salary at this point. Once NDA is submitted and the kidney trial is done, they will have less expenses.

So I think current management could just sell part of their positions, hold the rest, and sail off into the sunset.

All my comments are Rated As Pro.